Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2026-02-24 @ 7:45 PM
Study NCT ID:
NCT02849951
Status:
TERMINATED
Last Update Posted:
2017-06-15
First Post:
2016-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Sponsor:
Prometheus Laboratories
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Ulcerative Colitis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Colitis | View |
| None | Colitis, Ulcerative | View |
| None | Ulcer | View |
| None | Colonic Diseases | View |
| None | Digestive System Diseases | View |
| None | Gastroenteritis | View |
| None | Gastrointestinal Diseases | View |
| None | Inflammatory Bowel Diseases | View |
| None | Intestinal Diseases | View |
| None | Pathologic Processes | View |
| None | Mesalamine | View |